Navigation Links
Hepatitis B Foundation awards UT School of Public Health professor
Date:1/8/2010

HOUSTON (Jan. 8, 2010) R. Palmer Beasley, M.D., Ashbel Smith Professor at The University of Texas School of Public Health, has been awarded the Hepatitis B Foundation's Distinguished Scientist Award 2010.

"The HBV vaccine, the first cancer vaccine, provides long-term protection against hepatitis B infection, which is responsible for a large proportion of liver cancer in the world. Ultimately, HBV can be eradicated," said Beasley. "This honor from the Hepatitis B Foundation provides another tool to encourage the world to use the vaccine vigorously."

For more than 18 years, Beasley served as dean of the UT School of Public Health. Beasley has pioneered work in perinatal hepatitis B virus transmission, which showed that mother-infant transmission was the most important factor in sustaining hepatitis B virus infection in Asia. He also did the definitive research that proved that hepatitis B causes primary liver cancer and led the global effort to convince the World Health Organization to establish the HBV vaccine as the first human cancer vaccine.

"Dr. Beasley's contributions to understanding the link between hepatitis B and liver cancer have saved thousands of lives. His work not only transformed our understanding of the cause of liver cancer, but then spearheaded the solution through vaccination," said Roberta B. Ness, M.D., dean of the UT School of Public Health. "We are certainly proud to call him one of our own."

This award is the highest scientific honor awarded by the foundation in recognition and appreciation for the research of hepatitis B.


'/>"/>

Contact: Jade Waddy
jade.waddy@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1

Related medicine news :

1. NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus
2. New Hepatitis C Treatment Shows Promise
3. NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is Wake-Up Call for Washington
4. Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US
5. Lloyd Wright's Alternative Medicine Has One of its Hepatitis C Viral Inhibitors Given Boost as Scripps Study Peptides Effectiveness
6. NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on Viral Hepatitis Detection, Management Funding
7. Lloyd Wright's Alternative Medicine Marketing Only Blueberry Extract with 45% of Hepatitis C Inhibitor Proanthocyanidin
8. African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C
9. Extending treatment after liver transplant may benefit patients with hepatitis C recurrence
10. Hepatitis B does not increase risk for pancreatic cancer
11. Brown & Toland Supports Fight Against Hepatitis B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , ... February 11, 2016 , ... ... healthcare industry, ranked among the top five firms in the “2015/2016 Best in ... Implementation Support and Staffing. KLAS is a research and insights firm on a ...
(Date:2/11/2016)... FL (PRWEB) , ... February 11, 2016 , ... ... and advocates will discuss how to improve care by making data on heart ... heart disease. The Summit on Transparency and Public Reporting of Pediatric and Congenital ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... and Reconstructive Surgery, Dallas plastic surgeon , Dr. Rod J. Rohrich, and ... surgery . Dr. Rohrich outlines recommendations for rhinoplasty surgeons when addressing this vital ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... clinical decision support technology, with highly adaptable algorithms, has been updated to help ... has signs and symptoms consistent with Zikas and a travel history to affected ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you ... Ray Clarke poses a question as a challenge for his readers to examine ... in the Being" (published by Partridge Singapore), Clarke explores the subject with more ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... Feb. 11, 2016   Health 2.0 , the ... health technologies, announced today " 10 Year Global Retrospective ... tech over the past ten years.   ... decade, Health 2.0 has served as the preeminent thought-leader ... with thousands of technologies, companies, innovators, and patient-activists through ...
(Date:2/11/2016)...  AfterPill.com is reporting that this week,s Centers for ... women who are at risk of unintended pregnancy impacts ... raises the risks of unprotected sex in particular.  ... to the Guttmacher Institute, there are 43 million women ... who have sex without the intention of becoming pregnant.  ...
(Date:2/11/2016)... Transformational M&A achieved through NPS and ... --> Transformational M&A achieved through NPS and Dyax acquisitions ... Transformational M&A achieved through NPS and Dyax acquisitions and ... future growth with most robust pipeline in Shire , ... growth with most robust pipeline in Shire , ...
Breaking Medicine Technology: